SCHEMBL848254

SCHEMBL848254

O=C(Nc1cnc2ccccc2c1)Oc1ccc(N2CCC(Cc3ccccc3)CC2)nc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.52
SCN9A Q15858 1/20 0.47
DGAT1 O75907 7/20 0.46
SMN1; SMN2 Q16637 5/20 0.45
TNF P01375 1/20 0.45
LMNA P02545 1/20 0.45
STAT3 P40763 1/20 0.45
NOD2 Q9HC29 1/20 0.45
NOD1 Q9Y239 1/20 0.45
CYP3A4 P08684 1/20 0.43
SOAT1 P35610 1/20 0.43
CHRM4 P08173 2/20 0.42
KDM4E B2RXH2 2/20 0.42
NPC1 O15118 2/20 0.42
HSD17B10 Q99714 2/20 0.42
TP53 P04637 1/20 0.42
RAB9A P51151 1/20 0.42
TRPV1 Q8NER1 2/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL847222 0.88 DGAT1 (0.45) FAAHSCN9ADGAT1SMN1; SMN2LMNA
SCHEMBL846587 0.85 FAAH (0.54) FAAHDGAT1SMN1; SMN2LMNACYP3A4
SCHEMBL846441 0.84 NPC1 (0.57) SMN1; SMN2LMNAKDM4ENPC1HSD17B10
SCHEMBL846604 0.77 KDR (0.58) FAAHSMN1; SMN2KDM4ENPC1RAB9A
SCHEMBL4108874 0.74 KDR (0.63) SMN1; SMN2LMNAKDM4ENPC1HSD17B10
SCHEMBL846733 0.72 TRPV1 (0.56) DGAT1KDM4ENPC1RAB9ATRPV1
SCHEMBL28495228 0.69 KDR (0.59) SCN9ASMN1; SMN2LMNAKDM4ENPC1
SCHEMBL31178440 0.68 FAAH (1.00) FAAHSMN1; SMN2KDM4ENPC1HSD17B10
SCHEMBL860051 0.68 KDM4E (0.49) SCN9ASMN1; SMN2LMNAKDM4ENPC1
SCHEMBL29739663 0.68 KCNH2 (0.51) DGAT1SMN1; SMN2LMNACYP3A4SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP claimed